ARCHIVES

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

This article is from The Cancer Letter archive.

Vol. 32 No. 42 | November 22, 2006

Download PDF Visit The Full Archive

Related Articles

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

September 30, 2005

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

Lung Screening Study Ties Up Advisors, Board Sends It Back To NCI For Revision.

June 29, 2001

In Brief: NCI Gets $937 Million For FY 79 As Congress Adjourns; Cancer Act Renewed For Two Years

October 20, 1978

In Brief: BMS Oncology Names New VP, Marketing; Hortobagyi Wins Freyer Medal; Prerez Honored

October 24, 1997